Literature DB >> 17389359

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.

Yusuke Mimura1, Yuka Mimura-Kimura, Katie Doores, Denise Golgher, Benjamin G Davis, Raymond A Dwek, Pauline M Rudd, Tim Elliott.   

Abstract

CD4(+) and CD8(+) T cell responses to endogenous retroviral envelope glycoprotein gp90 generate protective immunity to murine colon carcinoma CT26. A panel of I-A(d)-restricted T cell hybridomas recognize gp90 synthesized by CT26 cells but not by other gp90-expressing tumors. Here we report that antigenicity resides in an incompletely folded form of gp90 that is unique to CT26. In contrast to more compact forms of gp90 that are present in other tumors, this open conformer is captured by recycling I-A(d) on antigen-presenting cells and is processed intracellularly. Thus, gp90 acquires immunodominance via MHC-guided processing, and the generation of an MHC class II-restricted response can be controlled by the intracellular folding environment of antigen-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389359      PMCID: PMC1851603          DOI: 10.1073/pnas.0701307104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.

Authors:  Colin Watts
Journal:  Nat Immunol       Date:  2004-07       Impact factor: 25.606

2.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Authors:  Zarixia Zavala-Ruiz; Iwona Strug; Bruce D Walker; Philip J Norris; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

3.  Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.

Authors:  F Nadimi; J Moreno; F Momburg; A Heuser; S Fuchs; L Adorini; G J Hämmerling
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

4.  The presence of disulfide-linked gp70-p15(E) complexes in AKR murine leukemia virus.

Authors:  A Pinter; E Fleissner
Journal:  Virology       Date:  1977-12       Impact factor: 3.616

5.  T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing.

Authors:  P Lee; G R Matsueda; P M Allen
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

6.  Antigen recognition by T cells and B cells: recognition of cross-reactivity between native and denatured forms of globular antigens.

Authors:  R W Chesnut; R O Endres; H M Grey
Journal:  Clin Immunol Immunopathol       Date:  1980-03

7.  Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic.

Authors:  J Lippincott-Schwartz; L Yuan; C Tipper; M Amherdt; L Orci; R D Klausner
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

8.  A colon tumor model for anticancer agent evaluation.

Authors:  D P Griswold; T H Corbett
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

Review 9.  Endogenous mouse leukemia viruses.

Authors:  R Risser; J M Horowitz; J McCubrey
Journal:  Annu Rev Genet       Date:  1983       Impact factor: 16.830

10.  Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines.

Authors:  N Sato; M C Michaelides; M K Wallack
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

View more
  6 in total

1.  Processing of tumor antigen differentially impacts the development of helper and effector CD4+ T-cell responses.

Authors:  Dannie Bernard; Michael S Ventresca; Laura A Marshall; Carole Evelegh; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Authors:  James S Testa; Geraud S Apcher; Joseph D Comber; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

Review 3.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect.

Authors:  Amir-Hassan Zarnani; Monireh Torabi-Rahvar; Mahmood Bozorgmehr; Mehri Zareie; Nazanin Mojtabavi
Journal:  Cancer Res Treat       Date:  2014-11-27       Impact factor: 4.679

5.  Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources.

Authors:  AeRyon Kim; Isamu Z Hartman; Brad Poore; Tatiana Boronina; Robert N Cole; Nianbin Song; M Teresa Ciudad; Rachel R Caspi; Dolores Jaraquemada; Scheherazade Sadegh-Nasseri
Journal:  Nat Commun       Date:  2014-11-21       Impact factor: 14.919

Review 6.  Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways.

Authors:  Carol S K Leung
Journal:  Front Immunol       Date:  2015-09-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.